Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Cell Physiol ; 231(4): 829-36, 2016 04.
Article in English | MEDLINE | ID: mdl-26284581

ABSTRACT

Human Immunodeficiency Virus (HIV)-infected individuals are at increased risk for developing neurocognitive disorders and depression. These conditions collectively affect more than 50% of people living with HIV/AIDS and adversely impact adherence to HIV therapy. Thus, identification of early markers of neurocognitive impairment could lead to interventions that improve psychosocial functioning and slow or reverse disease progression through improved treatment adherence. Evidence has accumulated for the role and function of microRNAs in normal and pathological conditions. We have optimized a protocol to profile microRNAs in body fluids. Using this methodology, we have profiled plasma microRNA expression for 30 age-matched, HIV-infected (HIV(+) ) patients and identified highly sensitive and specific microRNA signatures distinguishing HIV(+) patients with cognitive impairment from those without cognitive impairment. These results justify follow-on studies to determine whether plasma microRNA signatures can be used as a screening or prognostic tool for HIV(+) patients with neurocognitive impairment. J. Cell. Physiol. 231: 829-836, 2016. © 2015 Wiley Periodicals, Inc.


Subject(s)
Cognitive Dysfunction/blood , Cognitive Dysfunction/complications , HIV Infections/blood , HIV Infections/complications , MicroRNAs/blood , Adult , Cognitive Dysfunction/genetics , Demography , HIV Infections/genetics , Humans , MicroRNAs/genetics , Middle Aged , ROC Curve , Real-Time Polymerase Chain Reaction , Reference Standards , Reproducibility of Results
SELECTION OF CITATIONS
SEARCH DETAIL
...